(Q39784407)

English

Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL. (English)

1 reference

Europe PubMed Central

14 September 2017

0 references

cancer diagnosis

1 reference

based on heuristic

inferred from title

author name string

Rami Al-Azab

1

1 reference

Europe PubMed Central

14 September 2017

Ants Toi

2

1 reference

Europe PubMed Central

14 September 2017

Gina Lockwood

3

1 reference

Europe PubMed Central

14 September 2017

Girish S Kulkarni

4

1 reference

Europe PubMed Central

14 September 2017

Neil Fleshner

5

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

69

1 reference

Europe PubMed Central

14 September 2017

1

1 reference

Europe PubMed Central

14 September 2017

103-107

1 reference

Europe PubMed Central

14 September 2017

Epidemiology of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Outcome of sextant biopsy according to gland volume

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

The influence of prostate size on cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Prostate cancer detection: relationship to prostate size

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Biological determinants of cancer progression in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Prostate biopsy: how many cores are enough?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.041

7 January 2021

Identifiers

10.1016/J.UROLOGY.2006.09.041

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39784407&oldid=2090340144"